Previous Page  11 / 25 Next Page
Information
Show Menu
Previous Page 11 / 25 Next Page
Page Background

Page 58

conferenceseries

.com

Volume 9, Issue 5 (Suppl)

J Bioequiv Availab, an open access journal

ISSN: 0975-0851

Pharmacy & Biopharma 2017

August 31-September 01, 2017 Philadelphia, USA

August 31-September 01, 2017 Philadelphia, USA

3

rd

International Conference on

Biopharmaceutics and Biologic Drugs

&

5

th

International Pharmacy Conference

J Bioequiv Availab 2017, 9:5 (Suppl)

DOI: 10.4172/0975-0851-C1-031

Effects of microbubble size on ultrasound-induced transdermal delivery of high-molecular-weight drugs

Chih-Hung Wang, Taiwan

Ai-Ho Liao, Taiwan

T

ransdermal drug delivery can be assisted and enhanced by sonophoresis with ultrasound (US)-aided microbubbles (MBs).

The conventional transdermal delivery of a wide range of high-molecular-weight drugs is limited by the outermost layer

of the epidermis, with the stratum corneum representing the main barrier to penetration across the skin. The present study

determined the different effects of various sizes ofMBs that underwent US exposure to enhance the transdermal delivery of high-

molecular-weight drugs. The effects of US-mediated MBs of different sizes (1.4, 2.1, and 3.5 μm) and ascorbyl tetraisopalmitate

(VC-IP, a cosmetic ingredient for skin lightening) on enhancing skin transdermal delivery were demonstrated both

in vitro

and

in vivo

. The results indicated that the US power intensities of a 3 W/cm2 penetration depth in the US group combined with

3.5-μm MBs and penetrating VC-IP (U+3.5) were 34% and 14% higher than those in the US group combined with 1.4-μm

MBs and penetrating VC-IP (U+1.4) and US combined with 2.1-μmMBs and penetrating VC-IP (U+2.1), respectively, for the

agarose phantoms; the corresponding increases for pigskin were 37% and 19%. In terms of the skin permeation of VC-IP, the

VC-IP concentrations in the U+3.5 group were 23% and 10% higher than those in the U+1.4 and U+2.1 groups, respectively.

The whitening effect (luminosity index) of mouse skin in the U+3.5 group significantly increased by 28% after 1 week and

34% after 2 weeks, while it tended to stabilize after 3 weeks (45%), in C57BL/6J mice over a 4-week experimental period. In

conclusion, to the best of our knowledge, this is the first study to demonstrate that US combined with MBs of different sizes

can produce different degrees of skin permeability to enhance the delivery of high-molecular-weight drugs like VC-IP for skin

brightness without damaging the skin.

chw@ms3.hinet.net